Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 36


Identification of miRNAs Enriched in Extracellular Vesicles Derived from Serum Samples of Breast Cancer Patients.

Ozawa PMM, Vieira E, Lemos DS, Souza ILM, Zanata SM, Pankievicz VC, Tuleski TR, Souza EM, Wowk PF, Urban CA, Kuroda F, Lima RS, Almeida RC, Gradia DF, Cavalli IJ, Cavalli LR, Malheiros D, Ribeiro EMSF.

Biomolecules. 2020 Jan 16;10(1). pii: E150. doi: 10.3390/biom10010150.


The orphan nuclear receptor estrogen-related receptor beta (ERRβ) in triple-negative breast cancer.

Fernandez AI, Geng X, Chaldekas K, Harris B, Duttargi A, Berry VL, Berry DL, Mahajan A, Cavalli LR, Győrffy B, Tan M, Riggins RB.

Breast Cancer Res Treat. 2020 Feb;179(3):585-604. doi: 10.1007/s10549-019-05485-5. Epub 2019 Nov 19.


Integrated copy number and miRNA expression analysis in triple negative breast cancer of Latin American patients.

Sugita BM, Pereira SR, de Almeida RC, Gill M, Mahajan A, Duttargi A, Kirolikar S, Fadda P, de Lima RS, Urban CA, Makambi K, Madhavan S, Boca SM, Gusev Y, Cavalli IJ, Ribeiro EMSF, Cavalli LR.

Oncotarget. 2019 Oct 22;10(58):6184-6203. doi: 10.18632/oncotarget.27250. eCollection 2019 Oct 22.


Patterns of copy number alterations in primary breast tumors of South African patients and their impact on functional cellular pathways.

Lupicki K, Elifio-Esposito S, Fonseca AS, Weber SH, Sugita B, Langa BC, Pereira SRF, Govender D, Panieri E, Hiss DC, Abdul-Rasool S, Cavalli LR.

Int J Oncol. 2018 Dec;53(6):2745-2757. doi: 10.3892/ijo.2018.4589. Epub 2018 Oct 10.


Genomic comparison of early-passage conditionally reprogrammed breast cancer cells to their corresponding primary tumors.

Mahajan AS, Sugita BM, Duttargi AN, Saenz F, Krawczyk E, McCutcheon JN, Fonseca AS, Kallakury B, Pohlmann P, Gusev Y, Cavalli LR.

PLoS One. 2017 Oct 19;12(10):e0186190. doi: 10.1371/journal.pone.0186190. eCollection 2017.


Integrated molecular analysis of Tamoxifen-resistant invasive lobular breast cancer cells identifies MAPK and GRM/mGluR signaling as therapeutic vulnerabilities.

Stires H, Heckler MM, Fu X, Li Z, Grasso CS, Quist MJ, Lewis JA, Klimach U, Zwart A, Mahajan A, Győrffy B, Cavalli LR, Riggins RB.

Mol Cell Endocrinol. 2018 Aug 15;471:105-117. doi: 10.1016/j.mce.2017.09.024. Epub 2017 Sep 19.


Correlates of Triple Negative Breast Cancer and Chemotherapy Patterns in Black and White Women With Breast Cancer.

Sheppard VB, Cavalli LR, Dash C, Kanaan YM, Dilawari AA, Horton S, Makambi KH.

Clin Breast Cancer. 2017 Jun;17(3):232-238. doi: 10.1016/j.clbc.2016.12.006. Epub 2017 Jan 6.


In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis.

Hong SH, Tilan JU, Galli S, Acree R, Connors K, Mahajan A, Wietlisbach L, Polk T, Izycka-Swieszewska E, Lee YC, Cavalli LR, Rodriguez OC, Albanese C, Kitlinska JB.

J Vis Exp. 2016 Dec 9;(118). doi: 10.3791/54532.


Differentially expressed miRNAs in triple negative breast cancer between African-American and non-Hispanic white women.

Sugita B, Gill M, Mahajan A, Duttargi A, Kirolikar S, Almeida R, Regis K, Oluwasanmi OL, Marchi F, Marian C, Makambi K, Kallakury B, Sheahan L, Cavalli IJ, Ribeiro EM, Madhavan S, Boca S, Gusev Y, Cavalli LR.

Oncotarget. 2016 Nov 29;7(48):79274-79291. doi: 10.18632/oncotarget.13024.


Copy number and expression analysis of FOSL1, GSTP1, NTSR1, FADD and CCND1 genes in primary breast tumors with axillary lymph node metastasis.

Callegari CC, Cavalli IJ, Lima RS, Jucoski TS, Torresan C, Urban CA, Kuroda F, Anselmi KF, Cavalli LR, Ribeiro EM.

Cancer Genet. 2016 Jul-Aug;209(7-8):331-9. doi: 10.1016/j.cancergen.2016.06.003. Epub 2016 Jun 11.


Copy Number Analysis of the DLX4 and ERBB2 Genes in South African Breast Cancer Patients.

Langa BC, Oliveira MM, Pereira SR, Lupicki K, Marian C, Govender D, Panieri E, Hiss D, Cavalli IJ, Abdul-Rasool S, Cavalli LR.

Cytogenet Genome Res. 2015;146(3):195-203. doi: 10.1159/000439155. Epub 2015 Oct 28.


Increased copy number of the DLX4 homeobox gene in breast axillary lymph node metastasis.

Torresan C, Oliveira MM, Pereira SR, Ribeiro EM, Marian C, Gusev Y, Lima RS, Urban CA, Berg PE, Haddad BR, Cavalli IJ, Cavalli LR.

Cancer Genet. 2014 May;207(5):177-87. doi: 10.1016/j.cancergen.2014.04.007. Epub 2014 May 2.


Conditionally reprogrammed normal and transformed mouse mammary epithelial cells display a progenitor-cell-like phenotype.

Saenz FR, Ory V, AlOtaiby M, Rosenfield S, Furlong M, Cavalli LR, Johnson MD, Liu X, Schlegel R, Wellstein A, Riegel AT.

PLoS One. 2014 May 15;9(5):e97666. doi: 10.1371/journal.pone.0097666. eCollection 2014.


Radiation-generated short DNA fragments may perturb non-homologous end-joining and induce genomic instability.

Pang D, Winters TA, Jung M, Purkayastha S, Cavalli LR, Chasovkikh S, Haddad BR, Dritschilo A.

J Radiat Res. 2011;52(3):309-19.


Breast axillary lymph node metastasis.

Cavalli LR, Ellsworth RE, Klein C, Viale G.

Int J Breast Cancer. 2011;2011:304697. doi: 10.4061/2011/304697. Epub 2012 Feb 13. No abstract available.


Cooperation of tumor-derived HBx mutants and p53-249(ser) mutant in regulating cell proliferation, anchorage-independent growth and aneuploidy in a telomerase-immortalized normal human hepatocyte-derived cell line.

Jiang W, Wang XW, Unger T, Forgues M, Kim JW, Hussain SP, Bowman E, Spillare EA, Lipsky MM, Meck JM, Cavalli LR, Haddad BR, Harris CC.

Int J Cancer. 2010 Sep 1;127(5):1011-20. doi: 10.1002/ijc.25118.


Frequent loss of heterozygosity at the interferon regulatory factor-1 gene locus in breast cancer.

Cavalli LR, Riggins RB, Wang A, Clarke R, Haddad BR.

Breast Cancer Res Treat. 2010 May;121(1):227-31. doi: 10.1007/s10549-009-0509-8. Epub 2009 Aug 21.


Molecular markers of breast axillary lymph node metastasis.

Cavalli LR.

Expert Rev Mol Diagn. 2009 Jul;9(5):441-54. doi: 10.1586/erm.09.30. Review.


Amplification of the BP1 homeobox gene in breast cancer.

Cavalli LR, Man YG, Schwartz AM, Rone JD, Zhang Y, Urban CA, Lima RS, Haddad BR, Berg PE.

Cancer Genet Cytogenet. 2008 Nov;187(1):19-24. doi: 10.1016/j.cancergencyto.2008.07.004.


ERRgamma mediates tamoxifen resistance in novel models of invasive lobular breast cancer.

Riggins RB, Lan JP, Zhu Y, Klimach U, Zwart A, Cavalli LR, Haddad BR, Chen L, Gong T, Xuan J, Ethier SP, Clarke R.

Cancer Res. 2008 Nov 1;68(21):8908-17. doi: 10.1158/0008-5472.CAN-08-2669. Erratum in: Cancer Res. 2009 Feb 15;69(4):1695. Zhu, Yuelin [added].

Supplemental Content

Loading ...
Support Center